Rheumatoid Arthritis (RA) Market - 2019-2025
Rheumatoid arthritis (RA) is a fiery malady that advances after some time influencing the joints. The side effects aggravate after some time, which is the reason drug for RA gets basic to stop the irritation. There is no perpetual remedy for rheumatoid arthritis, however expanding examination exercises in regards to the equivalent show that reduction of side effects is accomplished when treatment starts in the underlying stages with solid prescriptions known as malady altering antirheumatic drugs (DMARDs).
The key factors propelling the growth of the rheumatoid arthritis drugs market are the launch of new biosimilars, rising prevalence of arthritis, and an increase in the acceptance of biopharmaceuticals.
The major factors that fuel the growth of the market are the rising incidence of rheumatoid arthritis and the increasing geriatric population. It usually affects the geriatric population, and the prevalence is seen higher in females as compared to males. Therefore, with the increasing geriatric population, the market is expected to experience growth in the coming years.
There are also several therapeutics and medications that have been developed in the recent years, to treat the symptoms of rheumatoid arthritis. Rheumatoid arthritis drugs management is generally associated with a high cost. Most commonly used drugs are disease-modifying anti-rheumatic drugs, non-steroidal anti-inflammatory drugs (NSAIDs), corticosteroids, and biologic drugs. Thus biologics account for a prominent market share, in terms of revenue, due to the considerably high cost of these medicines. However the costs of rheumatoid arthritis drugs and NSAIDs are less than biologics.
Thus, growing availability and awareness of safer drugs are anticipated to increase the global rheumatoid arthritis drugs market.
Get Sample Report PDF >>
The following manufacturers are covered:AbbVieRocheJohnson & JohnsonAmgen, Inc.PfizerMerckBristol-Myers SquibbUCBGlaxoSmithKlineSanofiAbbott LaboratoriesTeva Pharmaceutical
Scope of the Report
As per the scope of the report, rheumatoid arthritis is an autoimmune disorder that causes pain and inflammation in the joints of the body. Rheumatoid arthritis disease mostly affects the joints of the hand, wrists, elbows, knees, and ankles. It also affects the cardiac and respiratory system, and is known as systemic disease. It thus exhibits symptoms of swelling, redness, and warmth in the affected areas. Owing to the rise in the adoption of sedentary lifestyle, the patient pool is expected to witness a healthy growth.
Market segment by Type, the product can be split intoOralInjectionExternal
Market segment by Application, split intoMedical CarePersonal Care
This report provides comprehensive analysis ofKey market segments and sub-segmentsEvolving market trends and dynamicsChanging supply and demand scenariosQuantifying market opportunities through market sizing and market forecastingTracking current trends/opportunities/challengesCompetitive insightsOpportunity mapping in terms of technological breakthroughs
Browse Report »
Key Market Trends
NSAIDs Segment by Drug Class is Expected to be the Largest Segment During the Forecast Period
NSAIDs are being widely utilized for the symptomatic treatment of rheumatic disorders. DMARDs are also considered as the gold standard for the treatment of moderate to severe rheumatoid arthritis. Unlike conventional DMARDs, such as NSAIDs, which simply give symptomatic relief, biologic drugs are more efficient in the management of rheumatoid arthritis.
Asia-Pacific is Witnessing High Growth and is Expected to Follow the Same Trend Over the Forecast Period
The Asia-Pacific market is projected to witness high growth during the forecast period, due to increasing healthcare expenditure. Moreover, the low cost of manufacturing in China and India has resulted in the rise in the production facilities, attracting pharmaceutical and biotechnological giants to the Asia-Pacific region from across the world. The increase in the incidence of rheumatoid arthritis disease is also expected to fuel the market in the region during the forecast period.
A majority of rheumatoid arthritis drug products are being manufactured by key players. The market leaders in this industry have established their position in the market, and these manufacturers have a wide product range to offer and have an extensive distribution system across the world. Additionally, the emerging markets in the Asia-Pacific region are witnessing the entry of small players.
Customization of the Report
- Value chain analysis
- Consumer behavior analysis at country level
The report includes six parts, dealing with:1.) basic information;2.) the Asia Rheumatoid Arthritis (RA) Speaker Market;3.) the North American Rheumatoid Arthritis (RA) Speaker Market;4.) the European Rheumatoid Arthritis (RA) Speaker Market;5.) market entry and investment feasibility;6.) the report conclusion.
Table of Content:
1 Study Coverage
2 Executive Summary
3 Breakdown Data by Manufacturers
4 Breakdown Data by Type
5 Breakdown Data by Application
11 Company Profiles
12 Future Forecast
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
14 Value Chain and Sales Channels Analysis
15 Research Findings and Conclusion
The key insights of The report Research:
1.The report Research provides key statistics on the market status of the Rheumatoid Arthritis (RA) manufacturers and is a valuable source of guidance and direction for companies and individuals interested in the industry.2.The report Research provides a basic overview of the industry including its definition, applications and manufacturing technology.3.The report Research presents the company profile, product specifications, capacity, production value, and 2019-2018 market shares for key vendors.4.The total market is further divided by company, by country, and by application/type for the competitive landscape analysis.5.The report Research estimates 2019-2025 market development trends of Rheumatoid Arthritis (RA) industry.6.Analysis of upstream raw materials, downstream demand, and current market dynamics is also carried out7.The report Research makes some important proposals for a new project of Rheumatoid Arthritis (RA) Industry before evaluating its feasibility.
Reasons to Purchase this Report:
* Analyzing the outlook of the market with the recent trends and SWOT analysis* Market dynamics scenario, along with growth opportunities of the market in the years to come* Market segmentation analysis including qualitative and quantitative research incorporating the impact of economic and non-economic aspects* Regional and country level analysis integrating the demand and supply forces that are influencing the growth of the market.* Market value (USD Million) and volume (Units Million) data for each segment and sub-segment* Competitive landscape involving the market share of major players, along with the new projects and strategies adopted by players in the past five years* Comprehensive company profiles covering the product offerings, key financial information, recent developments, SWOT analysis, and strategies employed by the major market players* 1-year analyst support, along with the data support in excel format.
"Wise Guy Reports Is Part Of The Wise Guy Consultants Pvt. Ltd. And Offers Premium Progressive Statistical Surveying, Market Research Reports, Analysis & Forecast Data For Industries And Governments Around The Globe. Wise Guy Reports Features An Exhaustive List Of Market Research Reports From Hundreds Of Publishers Worldwide. We Boast A Database Spanning Virtually Every Market Category And An Even More Comprehensive Collection Of Market Research Reports Under These Categories And Sub-Categories".
Partner Relations & Marketing Manager
Ph: +1-646-845-9349 (US)
Ph: +44 208 133 9349 (UK)